
INNOWATER Conference: Europe’s Next Super Model for Innovation Systems, Internationalization and Tools for the European Water Sector
Date
Address
Event Type
Organiser type
Section
Event Location
Event Description
On June 19th, the INNOWATER conference ‘Europe’s Next Super Model - Innovation systems, internationalization and tools for the European Water Sector’ will take place in Copenhagen, Denmark.
The European Water Sector faces challenging circumstances. Public funding is cut across Europe, but innovation is ever more seen as a priority. A crucial question that arises is how governments can support innovation: What support can still be given by governments? What tools are required by SME’s to support them to innovate? How should these tools be linked to the government support systems?
In an interactive setting, the conference will address current support systems in Europe as well as opportunities for solid and sustainable innovation support models. Innovation experts together with European governments will present case studies, share best practices and discuss lessons learned within the INNOWATER partnership.
We are looking forward to your active contribution in shaping and defining the contours of Europe’s Next Super Model for innovation support!
For more information on the conference agenda, please click here.
Participating in the conference is free of charge.
Please register before June 14th by replying to this email.
Related Events
SMEs are the backbone of the European economy. Of the approximately 20 million SMEs in Europe, one third is active in the field of commerce.
COST will be a partner of the fourth European Innovation Summit to be held at the European Parliament in Brussels under the motto 'Building bridges – Creating Synergies'.
Knowledge4Innovation will be organising the 4th European Innovation Summit from 9 to 10 October 2012 in the European Parliament in Brussels.
An existing literature agrees that drug innovation has a significant average effect on extending longevity and improving quality of life. Recognizing the life-saving benefits from the development of new drugs, one of the key decisions faced by the authorities is how to bolster pharmaceutical innovation, and how to bear in mind the potential effects on drug innovation of policies that affect market size, such as policies towards intellectual property rights, procurement mechanisms and competition policy.
Pages
Events of the week
Jobs
EURACTIV News
- Bulgarian president hostile to coalition set to try form government
- Innovation for Carbon Neutrality in the Cement Industry [Promoted content]
- Sofia-Thessaloniki highway to become route for autonomous vehicles
- EU tells Kosovo, Serbia leaders to calm tensions, calls urgent meeting
- EU, US voice concern over Poland’s ‘Russian influence’ committee